Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RIGEL PHARMACEUTICALS INC | EVP & CMO | Common Stock | 72.5K | $127K | $1.75 | Feb 2, 2023 | Direct |
ALPINE IMMUNE SCIENCES, INC. | Chief Medical Officer | Stock Option (Right to buy) | 200K | Oct 2, 2023 | Direct | ||
RIGEL PHARMACEUTICALS INC | EVP & CMO | Employee Stock Option (right to buy) | 100K | Jan 26, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALPN | ALPINE IMMUNE SCIENCES, INC. | Oct 2, 2023 | 1 | $0 | 4 | Oct 4, 2023 | Chief Medical Officer |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Oct 2, 2023 | 0 | $0 | 3 | Oct 4, 2023 | Chief Medical Officer |
RIGL | RIGEL PHARMACEUTICALS INC | Feb 2, 2023 | 1 | -$8.95K | 4 | Feb 6, 2023 | EVP & CMO |
RIGL | RIGEL PHARMACEUTICALS INC | Jan 26, 2023 | 1 | $0 | 4 | Jan 30, 2023 | EVP & CMO |
RIGL | RIGEL PHARMACEUTICALS INC | Dec 28, 2022 | 1 | $0 | 4 | Dec 30, 2022 | EVP & CMO |
RIGL | RIGEL PHARMACEUTICALS INC | Jan 24, 2022 | 2 | $0 | 4 | Jan 26, 2022 | EVP & CMO |
RIGL | RIGEL PHARMACEUTICALS INC | Nov 4, 2021 | 1 | $0 | 4 | Nov 5, 2021 | EVP & CMO |